Company Filing History:
Years Active: 2000-2010
Title: Antonino Santoro: Innovator in Pharmaceutical Patents
Introduction
Antonino Santoro is a notable inventor based in Monza, Italy, recognized for his contributions to pharmaceutical innovations. With a total of 3 patents, he has made significant strides in the field of drug formulation and delivery systems.
Latest Patents
One of his latest patents is for a crystalline and stable form of Andolast. This invention describes a new crystalline Form A of Andolast disodium salt, which is triclinic and displays a thermal event at 98-112°C, melting with decomposition at about 400°C (DSC). This form is a non-hygroscopic solid, surprisingly stable under various humidity conditions, making it suitable for ordinary storage. Its stability allows for consistency and reproducibility in both chemical and pharmaceutical manufacturing processes, which are more viable and cost-effective compared to those used for highly hygroscopic solids.
Another significant patent is a matrix-type transdermal patch for steroid hormones. This invention refers to a transdermal patch designed for the release of Estradiol and at least one progestogen agent through the skin. The patch comprises an outer backing foil, a matrix, and a protective liner. The Estradiol and progestogen agents are present in the matrix in an oversaturated solution, which contains 1 to 5 wt% activated SiO2 and has a moisture content of less than 0.7 wt.-%. This patch can be utilized for hormonal replacement therapy.
Career Highlights
Throughout his career, Antonino Santoro has worked with reputable companies such as Rotta Research B.V. and Rottapharm B.V. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Lucio C. Rovati and Gunter Cordes, who have collaborated with him on various projects in the pharmaceutical field.
Conclusion
Antonino Santoro's innovative work in the pharmaceutical industry, particularly in drug formulation and delivery systems, showcases his significant contributions to the field. His patents reflect a commitment to improving drug stability and delivery methods, which can greatly benefit patients and healthcare providers alike.